
















Marketing for CDMOs and CROs (CRDMOs) is not like general pharmaceutical marketing and it differs in a way that very few digital agencies would understand. Yes, the fact that CRDMO purchase cycles are lengthy poses a challenge. But a bigger one is that a whole new set of people with entirely different priorities becomes your buyer at each stage of the drug development lifecycle, from target identification to commercial scale-up.
A research scientist considering CRO collaboration is interested in protocol flexibility and data integrity. When an outsourcing head evaluates the CDMO two years down the line, capacity, regulatory filings, and risks are of high priority to him. In order to reach the two and create the right impression at the right moment, an effective marketing team is required - a marketing team that understands the pharmaceutical value chain very well. That is what we have.
To acquire new clients of CDMOs/CROs can take between six and eighteen months. Marketing plans are based on short sales cycles and cannot cater to the long and multiple stages of the evaluation that the sponsor companies use. Unless you develop a marketing plan based on that fact, your marketing will be noise and not a pipeline.
Go through the websites of ten different CRDMOs. You will see that most websites talk about the quality of service, experience, and regulatory compliance, in the exact same way. If all your competitors sound alike, how would the sponsors differentiate among you? It is a positioning problem and one that costs you business. It is also an audience problem. A CRDMO working with innovator sponsors on new molecules is judged on scientific depth, tech transfer capability and IP confidentiality. One working with generic companies is judged on cost, capacity, speed to market and regulatory filing support. A website that speaks to both in the same voice convinces neither. We position you clearly for the partners you actually want to win.
You find fantastic sponsors at CPHI, DCAT, BIO International, and more. However, without a proper digital follow-up campaign consisting of relevant content, tailored engagement and monitored nurture flow, these conversations will not get anywhere. They just get colder, and you lose your investment in the event.
Seven unique services that are designed for the CDMO and CRO industries, by a team that understands the pharmaceutical value chain and its needs, and not an agency that simply adapted their offer to it.
While other digital marketing agencies educate themselves on your business, TechShu builds on the experience that comes from being an active part of the pharma ecosystem for 17 years now. It makes our decisions for you smarter and better.
We are different from other marketing firms in that we have an extensive knowledge of the entire process from target identification, drug discovery, through preclinical trials, clinical trials, to the approval and production process within the drug development life cycle.
Every step has its own mode of communication, its own stakeholder base, and its own marketing strategy. The communication that will connect with your researchers and scientists is entirely different from what would be used to connect with procurement officers, regulators, distributors, healthcare professionals, or commercial buyers.
As your CRO, CDMO, API supplier, formulator, or biotech bringing a new treatment to market whatever your role may be, we understand exactly who your target audience is, what their needs are, and when they need to receive information.
| Drug Development Stage | Primary Audience / Stakeholder | What They Need From Your Marketing |
|---|---|---|
| Target Identification & Drug Discovery | Research scientists, CSOs, founders of biotech and emerging pharma companies | Technical credibility, scientific depth, CRO capability messaging |
| Pre-Clinical Research | R&D heads, non-clinical study directors | DMPK, safety pharmacology, GLP compliance, CRO selection criteria |
| Clinical Trials (Phase I–III) | Clinical ops directors, procurement, study managers | CRO track record, therapeutic expertise, site network, trial efficiency |
| Regulatory Submission & Approval | Regulatory affairs heads, legal teams | Regulatory writing support, dossier capability, filing history |
| Clinical & Commercial Manufacturing (CDMO) | Supply chain heads, technical ops, procurement team | Capacity, GMP compliance, regulatory filings, tech transfer capability |
| API Supply | Formulation teams, procurement, supply chain | DMF filings, quality standards, sourcing reliability, audit readiness |
| Formulations & Dosing | Formulation team, product development | Proprietary formulations, clinical manufacturing capacity, scaling up experience |
The insight into the value chain of pharmaceuticals allows us to target the right audience segments at the right time, communicate the right messages to each of them, and reach them through the right communication channels in other words, to make sure that your brand will be communicated to the right people, in the right way, not in general but in such a targeted manner, which can only result from 17 years of direct pharma marketing experience.
As far as CDMOs and CROs go, this means that we do not create generic B2B campaigns; we create sponsor acquisition campaigns tailored for the stage of drug development pipeline of your target sponsors, the decision-making stakeholders at that stage and the information required by them to make that decision.
TechShu’s DMFlow process methodology, developed uniquely for the pharma outsourcing industry, operates through five distinct stages. The first and foremost aspect of this process lies in the fact that we have extensive pharma knowledge – unlike any other agency.
The initial step involves creating a map of your unique target sponsors, the stage at which they are at the drug development lifecycle, the capability positioning of your business, and the markets served. The pharmaceutical value chain understanding of ours comes into play here as we don’t have to learn from scratch what CDMOs and CROs do and who they sell to. Before we pen down even one sentence or plan out one campaign, we already have a good idea of who your perfect client is, what they need right now, and how the whole outsourcing decision process works for them.
We conduct an audit of your existing website, content, search presence, and digital footprint against the actual requirements of your target sponsors. We audit your positioning compared to competitors and find out the gaps where you’re missing opportunities for visibility and leads. We also examine if the messaging is addressed to the correct audience in the right stage of evaluation – a key component of the CDMO audit that most agencies ignore.
We develop a marketing strategy for CDMOs which will suit your budget, schedule and business development objectives. We pick up the right keywords, the right structure of the content, the right LinkedIn audience segments and the right approach for event marketing. The decisions are made based on our deep understanding of pharmaceutical buyer’s journey at different stages of development process and not on some trendy practices of digital marketing.
We carry out the strategy: creating content that will rank, implementing LinkedIn campaigns to the target sponsor accounts, running an event marketing program, and establishing a digital presence that ensures visibility of your capability messaging at all touchpoints of the sponsor evaluation process. Thanks to our industry knowledge, every piece of content we create speaks directly to the decision-makers.
We provide reporting on leads, sponsor accounts, and pipeline activities - not on page views and bounce rates. We understand the right kind of sources for inquiries, analyse, and plan the right kind of channels that work to influence the enquiry journey. When some channel doesn't produce leads, we optimize it.
Four results, evaluated in the context of your pipeline and not vanity metrics related to marketing.
More visits from actual sponsors and procurement teams looking to engage with a CDMO or CRO partner targeted by stage, by role, and by intent. This is not just traffic from general pharma audiences, but traffic that is far more likely to turn into RFPs from qualified sponsors.
Be seen in Google search results when sponsors are looking, show up in ChatGPT and Perplexity answers when sponsors are choosing which CDMO to approach, be seen when sponsors are walking the floor at events like CPHI. This is due to our deep knowledge of the pharmaceutical value chain.
Not just more leads, the right kind, at the right stage of the sponsorship process. Founders and research & development heads of biotechnology firms, start-up and mature pharmaceutical companies, procurement directors, clinical operations executives, business development directors from firms you wish to target. These leads will come with contextual information about what they've already engaged with.
Visibility and lead generation, when improved over 12 months, contribute to sustainable business growth. Out of the 10 leading pharmaceutical companies in India, 6 have partnered with TechShu not because we are the largest agency but because we are the one who truly understands their business right from the first day of engagement. 70% of our clients are with us for five years or more because the returns get better with each year
We measure what moves the pipeline and not what looks good in a report.
Years in pharma marketing
Of India’s top 10 pharma brands work with us
Of clients stay with us for 5+ years
Clients, across 20 industries
You are selling to a committee of buyers who are weighing a 6-18 month decision on outsourcing. The buyer will be different as the compound progresses through the various stages of its lifecycle. An executive who is choosing a CDMO for clinical manufacturing needs totally different things than an executive who is choosing a CRO for pre-clinical services. Regular pharma digital marketing ignores all that.
It's three channels working in concert – outsourcing-intent SEO for sponsors actively looking, account-based marketing via LinkedIn to reach procurement and clinical operations contacts at specific sponsors, and a digital strategy for CPHI, DCAT, and BIO International so the conversations at the shows don't go cold. Each channel feeds the other.
Since we understand the whole process of pharmaceutical product development starting from drug discovery through clinical trials up to its regulatory approval and launch. This knowledge helps us to define who the key sponsors are, at what stage of development they are and how to convince them in order to get selected instead of evaluated. More than 17 years of experience in pharma industry, 6 of the top 10 pharmaceutical companies in India work with us, unique marketing approach designed specifically for pharmaceutical market.
Competitor intelligence, CDMO search engine optimization and listings, demand generation by means of paid search and LinkedIn ABM, AI answers visibility (AEO), stage-and-role based content, event marketing for CPHI, DCAT and BIO, and enquiry-to-RFP pipeline management. Everything is created according to buyers' behavior patterns, typical for pharma outsourcing industry, rather than generic B2B approaches.
Month one: Competitor audit, keyword and AEO strategy and capability messaging update. Then: ABM targets lists, LinkedIn campaign, event marketing if CPHI or DCAT within scope and monthly pipeline report with enquiry tracking.
Most pharmaceutical marketing agencies are structured around brand and patient-focused pharma marketing, namely prescription promotion, patient engagement, and hospital brands. TechShu is structured around B2B pharmaceutical marketing and the outsourcing industry. We know the sponsor evaluation process, the credible signals needed, and the AI answer engines where sponsors go first to research CDMOs. It's not a repositioning – it's been our focus for 17+ years.
Free audit of your sponsor journey and benchmarking of your capability messaging versus competition.